nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR6—Alzheimer's disease	0.245	0.596	CbGaD
Loxapine—HTR3A—Memantine—Alzheimer's disease	0.163	0.543	CbGbCtD
Loxapine—SLC6A4—Alzheimer's disease	0.0938	0.228	CbGaD
Loxapine—HTR2A—Donepezil—Alzheimer's disease	0.0765	0.254	CbGbCtD
Loxapine—HTR2A—Alzheimer's disease	0.0721	0.175	CbGaD
Loxapine—DRD2—Memantine—Alzheimer's disease	0.0611	0.203	CbGbCtD
Loxapine—HTR2C—choroid plexus—Alzheimer's disease	0.0054	0.0674	CbGeAlD
Loxapine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00285	0.0355	CbGeAlD
Loxapine—Polydipsia—Donepezil—Alzheimer's disease	0.0028	0.0267	CcSEcCtD
Loxapine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00279	0.0348	CbGeAlD
Loxapine—HTR2A—choroid plexus—Alzheimer's disease	0.00271	0.0338	CbGeAlD
Loxapine—HTR7—locus ceruleus—Alzheimer's disease	0.00269	0.0335	CbGeAlD
Loxapine—Polydipsia—Memantine—Alzheimer's disease	0.00254	0.0242	CcSEcCtD
Loxapine—HTR5A—forebrain—Alzheimer's disease	0.00214	0.0266	CbGeAlD
Loxapine—Tardive dyskinesia—Memantine—Alzheimer's disease	0.00212	0.0202	CcSEcCtD
Loxapine—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.00207	0.0197	CcSEcCtD
Loxapine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00204	0.0254	CbGeAlD
Loxapine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.0017	0.0162	CcSEcCtD
Loxapine—HTR2A—locus ceruleus—Alzheimer's disease	0.00167	0.0209	CbGeAlD
Loxapine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00165	0.0206	CbGeAlD
Loxapine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00164	0.0204	CbGeAlD
Loxapine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.0016	0.0199	CbGeAlD
Loxapine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00158	0.0197	CbGeAlD
Loxapine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00154	0.0147	CcSEcCtD
Loxapine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00151	0.0144	CcSEcCtD
Loxapine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00149	0.0142	CcSEcCtD
Loxapine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00137	0.017	CbGeAlD
Loxapine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00133	0.0166	CbGeAlD
Loxapine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00127	0.0159	CbGeAlD
Loxapine—DRD2—telencephalic ventricle—Alzheimer's disease	0.0012	0.015	CbGeAlD
Loxapine—HTR5A—nervous system—Alzheimer's disease	0.00116	0.0145	CbGeAlD
Loxapine—Glaucoma—Donepezil—Alzheimer's disease	0.00115	0.011	CcSEcCtD
Loxapine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.00115	0.011	CcSEcCtD
Loxapine—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00113	0.0108	CcSEcCtD
Loxapine—HTR5A—central nervous system—Alzheimer's disease	0.00112	0.0139	CbGeAlD
Loxapine—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.00109	0.0104	CcSEcCtD
Loxapine—Numbness—Donepezil—Alzheimer's disease	0.00105	0.00999	CcSEcCtD
Loxapine—Glaucoma—Memantine—Alzheimer's disease	0.00105	0.00998	CcSEcCtD
Loxapine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00105	0.00998	CcSEcCtD
Loxapine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.00102	0.00977	CcSEcCtD
Loxapine—Glaucoma—Rivastigmine—Alzheimer's disease	0.00102	0.00977	CcSEcCtD
Loxapine—Sensory loss—Donepezil—Alzheimer's disease	0.001	0.00956	CcSEcCtD
Loxapine—Numbness—Memantine—Alzheimer's disease	0.000951	0.00907	CcSEcCtD
Loxapine—Dysarthria—Donepezil—Alzheimer's disease	0.000918	0.00875	CcSEcCtD
Loxapine—HTR1E—forebrain—Alzheimer's disease	0.000912	0.0114	CbGeAlD
Loxapine—Sensory loss—Memantine—Alzheimer's disease	0.00091	0.00868	CcSEcCtD
Loxapine—Gait disturbance—Donepezil—Alzheimer's disease	0.00089	0.00848	CcSEcCtD
Loxapine—HTR5A—brain—Alzheimer's disease	0.000886	0.0111	CbGeAlD
Loxapine—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000844	0.00804	CcSEcCtD
Loxapine—Wheezing—Donepezil—Alzheimer's disease	0.000844	0.00804	CcSEcCtD
Loxapine—Dyskinesia—Memantine—Alzheimer's disease	0.000839	0.008	CcSEcCtD
Loxapine—HTR1E—telencephalon—Alzheimer's disease	0.000838	0.0105	CbGeAlD
Loxapine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00083	0.00791	CcSEcCtD
Loxapine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000821	0.00782	CcSEcCtD
Loxapine—HTR1B—blood vessel—Alzheimer's disease	0.000817	0.0102	CbGeAlD
Loxapine—Dysarthria—Rivastigmine—Alzheimer's disease	0.000816	0.00777	CcSEcCtD
Loxapine—Gait disturbance—Memantine—Alzheimer's disease	0.000808	0.0077	CcSEcCtD
Loxapine—Dry eye—Donepezil—Alzheimer's disease	0.000802	0.00765	CcSEcCtD
Loxapine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000794	0.00991	CbGeAlD
Loxapine—HTR1D—blood vessel—Alzheimer's disease	0.000791	0.00987	CbGeAlD
Loxapine—Gait disturbance—Rivastigmine—Alzheimer's disease	0.00079	0.00753	CcSEcCtD
Loxapine—Urinary retention—Galantamine—Alzheimer's disease	0.000774	0.00737	CcSEcCtD
Loxapine—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000749	0.00714	CcSEcCtD
Loxapine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000743	0.00708	CcSEcCtD
Loxapine—HTR6—forebrain—Alzheimer's disease	0.000715	0.00893	CbGeAlD
Loxapine—Dysphagia—Galantamine—Alzheimer's disease	0.000703	0.0067	CcSEcCtD
Loxapine—DRD5—forebrain—Alzheimer's disease	0.000696	0.00869	CbGeAlD
Loxapine—HTR6—telencephalon—Alzheimer's disease	0.000658	0.00821	CbGeAlD
Loxapine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.000643	0.00613	CcSEcCtD
Loxapine—DRD5—telencephalon—Alzheimer's disease	0.00064	0.00799	CbGeAlD
Loxapine—Weight decreased—Galantamine—Alzheimer's disease	0.000636	0.00606	CcSEcCtD
Loxapine—HTR7—blood vessel—Alzheimer's disease	0.00063	0.00786	CbGeAlD
Loxapine—Renal failure—Galantamine—Alzheimer's disease	0.000616	0.00587	CcSEcCtD
Loxapine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000616	0.00587	CcSEcCtD
Loxapine—Urinary retention—Donepezil—Alzheimer's disease	0.0006	0.00571	CcSEcCtD
Loxapine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000584	0.00557	CcSEcCtD
Loxapine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000576	0.00549	CcSEcCtD
Loxapine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000571	0.00545	CcSEcCtD
Loxapine—Hepatitis—Galantamine—Alzheimer's disease	0.000563	0.00536	CcSEcCtD
Loxapine—Psychotic disorder—Memantine—Alzheimer's disease	0.000559	0.00533	CcSEcCtD
Loxapine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000547	0.00521	CcSEcCtD
Loxapine—Dysphagia—Donepezil—Alzheimer's disease	0.000545	0.00519	CcSEcCtD
Loxapine—Urinary retention—Memantine—Alzheimer's disease	0.000544	0.00519	CcSEcCtD
Loxapine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000533	0.00508	CcSEcCtD
Loxapine—DRD1—forebrain—Alzheimer's disease	0.000532	0.00664	CbGeAlD
Loxapine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000523	0.00498	CcSEcCtD
Loxapine—HTR3A—forebrain—Alzheimer's disease	0.000514	0.00641	CbGeAlD
Loxapine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000511	0.00488	CcSEcCtD
Loxapine—Angiopathy—Galantamine—Alzheimer's disease	0.000511	0.00487	CcSEcCtD
Loxapine—Weight increased—Donepezil—Alzheimer's disease	0.000496	0.00473	CcSEcCtD
Loxapine—HTR1E—nervous system—Alzheimer's disease	0.000495	0.00617	CbGeAlD
Loxapine—Dysphagia—Memantine—Alzheimer's disease	0.000495	0.00472	CcSEcCtD
Loxapine—Weight decreased—Donepezil—Alzheimer's disease	0.000493	0.0047	CcSEcCtD
Loxapine—DRD1—telencephalon—Alzheimer's disease	0.000489	0.0061	CbGeAlD
Loxapine—Bronchospasm—Memantine—Alzheimer's disease	0.000487	0.00464	CcSEcCtD
Loxapine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000484	0.00461	CcSEcCtD
Loxapine—Tension—Galantamine—Alzheimer's disease	0.000481	0.00458	CcSEcCtD
Loxapine—Dysgeusia—Galantamine—Alzheimer's disease	0.00048	0.00457	CcSEcCtD
Loxapine—Renal failure—Donepezil—Alzheimer's disease	0.000478	0.00455	CcSEcCtD
Loxapine—HTR1E—central nervous system—Alzheimer's disease	0.000476	0.00594	CbGeAlD
Loxapine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000476	0.00454	CcSEcCtD
Loxapine—Jaundice—Donepezil—Alzheimer's disease	0.000474	0.00451	CcSEcCtD
Loxapine—HTR3A—telencephalon—Alzheimer's disease	0.000473	0.0059	CbGeAlD
Loxapine—Muscle spasms—Galantamine—Alzheimer's disease	0.000471	0.00449	CcSEcCtD
Loxapine—Vision blurred—Galantamine—Alzheimer's disease	0.000462	0.0044	CcSEcCtD
Loxapine—Tremor—Galantamine—Alzheimer's disease	0.000459	0.00438	CcSEcCtD
Loxapine—Weight increased—Memantine—Alzheimer's disease	0.00045	0.00429	CcSEcCtD
Loxapine—Agitation—Galantamine—Alzheimer's disease	0.00045	0.00429	CcSEcCtD
Loxapine—Weight decreased—Memantine—Alzheimer's disease	0.000448	0.00427	CcSEcCtD
Loxapine—Asenapine—HTR6—Alzheimer's disease	0.000446	0.111	CrCbGaD
Loxapine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000442	0.00421	CcSEcCtD
Loxapine—Weight increased—Rivastigmine—Alzheimer's disease	0.00044	0.0042	CcSEcCtD
Loxapine—Syncope—Galantamine—Alzheimer's disease	0.000439	0.00419	CcSEcCtD
Loxapine—DRD4—brain—Alzheimer's disease	0.000439	0.00547	CbGeAlD
Loxapine—Weight decreased—Rivastigmine—Alzheimer's disease	0.000438	0.00417	CcSEcCtD
Loxapine—Hepatitis—Donepezil—Alzheimer's disease	0.000436	0.00416	CcSEcCtD
Loxapine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000434	0.00414	CcSEcCtD
Loxapine—CHRM4—nervous system—Alzheimer's disease	0.000434	0.00541	CbGeAlD
Loxapine—Renal failure—Memantine—Alzheimer's disease	0.000434	0.00413	CcSEcCtD
Loxapine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000432	0.00411	CcSEcCtD
Loxapine—HTR1B—forebrain—Alzheimer's disease	0.000431	0.00538	CbGeAlD
Loxapine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000431	0.0041	CcSEcCtD
Loxapine—CHRM2—forebrain—Alzheimer's disease	0.000429	0.00535	CbGeAlD
Loxapine—SLC6A3—forebrain—Alzheimer's disease	0.000428	0.00534	CbGeAlD
Loxapine—Cough—Galantamine—Alzheimer's disease	0.000428	0.00408	CcSEcCtD
Loxapine—Convulsion—Galantamine—Alzheimer's disease	0.000424	0.00405	CcSEcCtD
Loxapine—Renal failure—Rivastigmine—Alzheimer's disease	0.000424	0.00404	CcSEcCtD
Loxapine—Hypertension—Galantamine—Alzheimer's disease	0.000423	0.00403	CcSEcCtD
Loxapine—CHRM4—central nervous system—Alzheimer's disease	0.000418	0.00521	CbGeAlD
Loxapine—HTR1D—forebrain—Alzheimer's disease	0.000417	0.00521	CbGeAlD
Loxapine—Chest pain—Galantamine—Alzheimer's disease	0.000417	0.00398	CcSEcCtD
Loxapine—HTR2C—forebrain—Alzheimer's disease	0.000413	0.00516	CbGeAlD
Loxapine—Agranulocytosis—Memantine—Alzheimer's disease	0.000412	0.00392	CcSEcCtD
Loxapine—Dry mouth—Galantamine—Alzheimer's disease	0.000408	0.00389	CcSEcCtD
Loxapine—ADRB1—forebrain—Alzheimer's disease	0.000406	0.00506	CbGeAlD
Loxapine—DRD3—nervous system—Alzheimer's disease	0.000403	0.00503	CbGeAlD
Loxapine—Confusional state—Galantamine—Alzheimer's disease	0.000403	0.00384	CcSEcCtD
Loxapine—HTR1B—telencephalon—Alzheimer's disease	0.000396	0.00495	CbGeAlD
Loxapine—Hepatitis—Memantine—Alzheimer's disease	0.000396	0.00377	CcSEcCtD
Loxapine—CHRM2—telencephalon—Alzheimer's disease	0.000394	0.00492	CbGeAlD
Loxapine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000394	0.00376	CcSEcCtD
Loxapine—Shock—Galantamine—Alzheimer's disease	0.000393	0.00375	CcSEcCtD
Loxapine—SLC6A3—telencephalon—Alzheimer's disease	0.000393	0.00491	CbGeAlD
Loxapine—HTR2A—blood vessel—Alzheimer's disease	0.000393	0.0049	CbGeAlD
Loxapine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000392	0.00374	CcSEcCtD
Loxapine—SLC6A4—forebrain—Alzheimer's disease	0.000392	0.00489	CbGeAlD
Loxapine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000391	0.00373	CcSEcCtD
Loxapine—CHRM1—forebrain—Alzheimer's disease	0.00039	0.00487	CbGeAlD
Loxapine—Tachycardia—Galantamine—Alzheimer's disease	0.00039	0.00372	CcSEcCtD
Loxapine—DRD3—central nervous system—Alzheimer's disease	0.000388	0.00485	CbGeAlD
Loxapine—HTR6—nervous system—Alzheimer's disease	0.000388	0.00485	CbGeAlD
Loxapine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000387	0.00369	CcSEcCtD
Loxapine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000385	0.00367	CcSEcCtD
Loxapine—Alopecia—Donepezil—Alzheimer's disease	0.000385	0.00367	CcSEcCtD
Loxapine—HTR1D—telencephalon—Alzheimer's disease	0.000384	0.00479	CbGeAlD
Loxapine—HTR2C—telencephalon—Alzheimer's disease	0.00038	0.00474	CbGeAlD
Loxapine—HTR1E—brain—Alzheimer's disease	0.000378	0.00472	CbGeAlD
Loxapine—DRD5—nervous system—Alzheimer's disease	0.000378	0.00472	CbGeAlD
Loxapine—HTR6—central nervous system—Alzheimer's disease	0.000374	0.00466	CbGeAlD
Loxapine—Hypotension—Galantamine—Alzheimer's disease	0.000374	0.00356	CcSEcCtD
Loxapine—ADRB1—telencephalon—Alzheimer's disease	0.000373	0.00465	CbGeAlD
Loxapine—Tension—Donepezil—Alzheimer's disease	0.000373	0.00355	CcSEcCtD
Loxapine—Dysgeusia—Donepezil—Alzheimer's disease	0.000372	0.00354	CcSEcCtD
Loxapine—Muscle spasms—Donepezil—Alzheimer's disease	0.000365	0.00348	CcSEcCtD
Loxapine—DRD5—central nervous system—Alzheimer's disease	0.000364	0.00454	CbGeAlD
Loxapine—Insomnia—Galantamine—Alzheimer's disease	0.000362	0.00345	CcSEcCtD
Loxapine—SLC6A4—telencephalon—Alzheimer's disease	0.00036	0.0045	CbGeAlD
Loxapine—Angiopathy—Memantine—Alzheimer's disease	0.000359	0.00342	CcSEcCtD
Loxapine—Paraesthesia—Galantamine—Alzheimer's disease	0.000359	0.00342	CcSEcCtD
Loxapine—CHRM1—telencephalon—Alzheimer's disease	0.000359	0.00448	CbGeAlD
Loxapine—Vision blurred—Donepezil—Alzheimer's disease	0.000358	0.00341	CcSEcCtD
Loxapine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000357	0.0034	CcSEcCtD
Loxapine—Tremor—Donepezil—Alzheimer's disease	0.000356	0.00339	CcSEcCtD
Loxapine—Somnolence—Galantamine—Alzheimer's disease	0.000355	0.00339	CcSEcCtD
Loxapine—HRH2—nervous system—Alzheimer's disease	0.000355	0.00443	CbGeAlD
Loxapine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000352	0.00335	CcSEcCtD
Loxapine—Alopecia—Memantine—Alzheimer's disease	0.00035	0.00334	CcSEcCtD
Loxapine—CHRM3—forebrain—Alzheimer's disease	0.000349	0.00436	CbGeAlD
Loxapine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000349	0.00333	CcSEcCtD
Loxapine—Agitation—Donepezil—Alzheimer's disease	0.000349	0.00333	CcSEcCtD
Loxapine—HTR1A—forebrain—Alzheimer's disease	0.000348	0.00434	CbGeAlD
Loxapine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000345	0.00329	CcSEcCtD
Loxapine—SLC6A2—forebrain—Alzheimer's disease	0.000345	0.0043	CbGeAlD
Loxapine—Fatigue—Galantamine—Alzheimer's disease	0.000345	0.00329	CcSEcCtD
Loxapine—Alopecia—Rivastigmine—Alzheimer's disease	0.000342	0.00326	CcSEcCtD
Loxapine—Constipation—Galantamine—Alzheimer's disease	0.000342	0.00326	CcSEcCtD
Loxapine—HRH2—central nervous system—Alzheimer's disease	0.000342	0.00426	CbGeAlD
Loxapine—Syncope—Donepezil—Alzheimer's disease	0.00034	0.00325	CcSEcCtD
Loxapine—CHRM5—nervous system—Alzheimer's disease	0.000339	0.00423	CbGeAlD
Loxapine—Tension—Memantine—Alzheimer's disease	0.000338	0.00322	CcSEcCtD
Loxapine—Dysgeusia—Memantine—Alzheimer's disease	0.000338	0.00322	CcSEcCtD
Loxapine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000334	0.00318	CcSEcCtD
Loxapine—HTR7—forebrain—Alzheimer's disease	0.000333	0.00415	CbGeAlD
Loxapine—CHRM4—brain—Alzheimer's disease	0.000332	0.00414	CbGeAlD
Loxapine—Cough—Donepezil—Alzheimer's disease	0.000331	0.00316	CcSEcCtD
Loxapine—Tension—Rivastigmine—Alzheimer's disease	0.000331	0.00315	CcSEcCtD
Loxapine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00033	0.00315	CcSEcCtD
Loxapine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000329	0.00314	CcSEcCtD
Loxapine—Convulsion—Donepezil—Alzheimer's disease	0.000329	0.00314	CcSEcCtD
Loxapine—Hypertension—Donepezil—Alzheimer's disease	0.000328	0.00312	CcSEcCtD
Loxapine—CHRM5—central nervous system—Alzheimer's disease	0.000327	0.00407	CbGeAlD
Loxapine—Vision blurred—Memantine—Alzheimer's disease	0.000325	0.0031	CcSEcCtD
Loxapine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000324	0.00309	CcSEcCtD
Loxapine—Chest pain—Donepezil—Alzheimer's disease	0.000323	0.00308	CcSEcCtD
Loxapine—Tremor—Memantine—Alzheimer's disease	0.000323	0.00308	CcSEcCtD
Loxapine—CHRM3—telencephalon—Alzheimer's disease	0.000321	0.00401	CbGeAlD
Loxapine—ADRA1A—forebrain—Alzheimer's disease	0.000321	0.004	CbGeAlD
Loxapine—HTR1A—telencephalon—Alzheimer's disease	0.00032	0.00399	CbGeAlD
Loxapine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000318	0.00303	CcSEcCtD
Loxapine—SLC6A2—telencephalon—Alzheimer's disease	0.000317	0.00396	CbGeAlD
Loxapine—Agitation—Memantine—Alzheimer's disease	0.000317	0.00302	CcSEcCtD
Loxapine—Dry mouth—Donepezil—Alzheimer's disease	0.000316	0.00301	CcSEcCtD
Loxapine—Tremor—Rivastigmine—Alzheimer's disease	0.000316	0.00301	CcSEcCtD
Loxapine—DRD2—forebrain—Alzheimer's disease	0.000314	0.00392	CbGeAlD
Loxapine—Confusional state—Donepezil—Alzheimer's disease	0.000312	0.00298	CcSEcCtD
Loxapine—Agitation—Rivastigmine—Alzheimer's disease	0.00031	0.00295	CcSEcCtD
Loxapine—ADRA1B—nervous system—Alzheimer's disease	0.00031	0.00387	CbGeAlD
Loxapine—Oedema—Donepezil—Alzheimer's disease	0.00031	0.00295	CcSEcCtD
Loxapine—Syncope—Memantine—Alzheimer's disease	0.000309	0.00295	CcSEcCtD
Loxapine—Leukopenia—Memantine—Alzheimer's disease	0.000309	0.00294	CcSEcCtD
Loxapine—DRD3—brain—Alzheimer's disease	0.000308	0.00385	CbGeAlD
Loxapine—HTR7—telencephalon—Alzheimer's disease	0.000306	0.00381	CbGeAlD
Loxapine—Shock—Donepezil—Alzheimer's disease	0.000305	0.00291	CcSEcCtD
Loxapine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000304	0.0029	CcSEcCtD
Loxapine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000303	0.00289	CcSEcCtD
Loxapine—Loss of consciousness—Memantine—Alzheimer's disease	0.000303	0.00289	CcSEcCtD
Loxapine—Syncope—Rivastigmine—Alzheimer's disease	0.000302	0.00288	CcSEcCtD
Loxapine—Cough—Memantine—Alzheimer's disease	0.000301	0.00287	CcSEcCtD
Loxapine—Convulsion—Memantine—Alzheimer's disease	0.000299	0.00285	CcSEcCtD
Loxapine—ADRA1B—central nervous system—Alzheimer's disease	0.000298	0.00372	CbGeAlD
Loxapine—Hypertension—Memantine—Alzheimer's disease	0.000298	0.00284	CcSEcCtD
Loxapine—HTR6—brain—Alzheimer's disease	0.000297	0.0037	CbGeAlD
Loxapine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000296	0.00283	CcSEcCtD
Loxapine—ADRA1A—telencephalon—Alzheimer's disease	0.000295	0.00368	CbGeAlD
Loxapine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000295	0.00281	CcSEcCtD
Loxapine—Cough—Rivastigmine—Alzheimer's disease	0.000294	0.00281	CcSEcCtD
Loxapine—Chest pain—Memantine—Alzheimer's disease	0.000294	0.0028	CcSEcCtD
Loxapine—Convulsion—Rivastigmine—Alzheimer's disease	0.000292	0.00279	CcSEcCtD
Loxapine—Hypertension—Rivastigmine—Alzheimer's disease	0.000291	0.00278	CcSEcCtD
Loxapine—Hypotension—Donepezil—Alzheimer's disease	0.00029	0.00276	CcSEcCtD
Loxapine—DRD2—telencephalon—Alzheimer's disease	0.000289	0.00361	CbGeAlD
Loxapine—DRD5—brain—Alzheimer's disease	0.000289	0.00361	CbGeAlD
Loxapine—DRD1—nervous system—Alzheimer's disease	0.000289	0.0036	CbGeAlD
Loxapine—Chest pain—Rivastigmine—Alzheimer's disease	0.000287	0.00274	CcSEcCtD
Loxapine—Dry mouth—Memantine—Alzheimer's disease	0.000287	0.00274	CcSEcCtD
Loxapine—Asthenia—Galantamine—Alzheimer's disease	0.000287	0.00273	CcSEcCtD
Loxapine—Confusional state—Memantine—Alzheimer's disease	0.000284	0.0027	CcSEcCtD
Loxapine—Oedema—Memantine—Alzheimer's disease	0.000281	0.00268	CcSEcCtD
Loxapine—ADRA2C—telencephalon—Alzheimer's disease	0.000281	0.00351	CbGeAlD
Loxapine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000281	0.00268	CcSEcCtD
Loxapine—Insomnia—Donepezil—Alzheimer's disease	0.00028	0.00267	CcSEcCtD
Loxapine—HTR3A—nervous system—Alzheimer's disease	0.000279	0.00348	CbGeAlD
Loxapine—Paraesthesia—Donepezil—Alzheimer's disease	0.000278	0.00265	CcSEcCtD
Loxapine—DRD1—central nervous system—Alzheimer's disease	0.000278	0.00347	CbGeAlD
Loxapine—Confusional state—Rivastigmine—Alzheimer's disease	0.000278	0.00265	CcSEcCtD
Loxapine—Shock—Memantine—Alzheimer's disease	0.000277	0.00264	CcSEcCtD
Loxapine—Dyspnoea—Donepezil—Alzheimer's disease	0.000276	0.00263	CcSEcCtD
Loxapine—Nervous system disorder—Memantine—Alzheimer's disease	0.000276	0.00263	CcSEcCtD
Loxapine—Somnolence—Donepezil—Alzheimer's disease	0.000275	0.00263	CcSEcCtD
Loxapine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000275	0.00263	CcSEcCtD
Loxapine—Oedema—Rivastigmine—Alzheimer's disease	0.000275	0.00262	CcSEcCtD
Loxapine—Tachycardia—Memantine—Alzheimer's disease	0.000275	0.00262	CcSEcCtD
Loxapine—HRH2—brain—Alzheimer's disease	0.000271	0.00339	CbGeAlD
Loxapine—Shock—Rivastigmine—Alzheimer's disease	0.000271	0.00258	CcSEcCtD
Loxapine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00027	0.00257	CcSEcCtD
Loxapine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000269	0.00257	CcSEcCtD
Loxapine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000269	0.00256	CcSEcCtD
Loxapine—HTR3A—central nervous system—Alzheimer's disease	0.000269	0.00335	CbGeAlD
Loxapine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000268	0.00255	CcSEcCtD
Loxapine—Fatigue—Donepezil—Alzheimer's disease	0.000267	0.00255	CcSEcCtD
Loxapine—Constipation—Donepezil—Alzheimer's disease	0.000265	0.00253	CcSEcCtD
Loxapine—Dizziness—Galantamine—Alzheimer's disease	0.000264	0.00252	CcSEcCtD
Loxapine—Hypotension—Memantine—Alzheimer's disease	0.000263	0.00251	CcSEcCtD
Loxapine—Zuclopenthixol—HTR6—Alzheimer's disease	0.000261	0.0647	CrCbGaD
Loxapine—CHRM5—brain—Alzheimer's disease	0.000259	0.00323	CbGeAlD
Loxapine—Hypotension—Rivastigmine—Alzheimer's disease	0.000257	0.00245	CcSEcCtD
Loxapine—Cyproheptadine—HTR6—Alzheimer's disease	0.000256	0.0636	CrCbGaD
Loxapine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000255	0.00243	CcSEcCtD
Loxapine—Insomnia—Memantine—Alzheimer's disease	0.000254	0.00243	CcSEcCtD
Loxapine—Vomiting—Galantamine—Alzheimer's disease	0.000254	0.00242	CcSEcCtD
Loxapine—Paraesthesia—Memantine—Alzheimer's disease	0.000253	0.00241	CcSEcCtD
Loxapine—Rash—Galantamine—Alzheimer's disease	0.000252	0.0024	CcSEcCtD
Loxapine—Dermatitis—Galantamine—Alzheimer's disease	0.000252	0.0024	CcSEcCtD
Loxapine—Dyspnoea—Memantine—Alzheimer's disease	0.000251	0.00239	CcSEcCtD
Loxapine—Headache—Galantamine—Alzheimer's disease	0.00025	0.00239	CcSEcCtD
Loxapine—Somnolence—Memantine—Alzheimer's disease	0.00025	0.00238	CcSEcCtD
Loxapine—Insomnia—Rivastigmine—Alzheimer's disease	0.000249	0.00237	CcSEcCtD
Loxapine—HRH1—forebrain—Alzheimer's disease	0.000248	0.0031	CbGeAlD
Loxapine—Olanzapine—HTR6—Alzheimer's disease	0.000248	0.0616	CrCbGaD
Loxapine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000247	0.00236	CcSEcCtD
Loxapine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000245	0.00234	CcSEcCtD
Loxapine—Somnolence—Rivastigmine—Alzheimer's disease	0.000245	0.00233	CcSEcCtD
Loxapine—ADRA2A—forebrain—Alzheimer's disease	0.000244	0.00304	CbGeAlD
Loxapine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000243	0.00232	CcSEcCtD
Loxapine—Fatigue—Memantine—Alzheimer's disease	0.000243	0.00231	CcSEcCtD
Loxapine—Constipation—Memantine—Alzheimer's disease	0.000241	0.00229	CcSEcCtD
Loxapine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000238	0.00227	CcSEcCtD
Loxapine—Nausea—Galantamine—Alzheimer's disease	0.000238	0.00226	CcSEcCtD
Loxapine—Fatigue—Rivastigmine—Alzheimer's disease	0.000237	0.00226	CcSEcCtD
Loxapine—ADRA1B—brain—Alzheimer's disease	0.000237	0.00296	CbGeAlD
Loxapine—Constipation—Rivastigmine—Alzheimer's disease	0.000235	0.00224	CcSEcCtD
Loxapine—HTR2A—embryo—Alzheimer's disease	0.000234	0.00293	CbGeAlD
Loxapine—HTR1B—nervous system—Alzheimer's disease	0.000234	0.00292	CbGeAlD
Loxapine—CHRM2—nervous system—Alzheimer's disease	0.000233	0.0029	CbGeAlD
Loxapine—SLC6A3—nervous system—Alzheimer's disease	0.000232	0.0029	CbGeAlD
Loxapine—Feeling abnormal—Memantine—Alzheimer's disease	0.000232	0.00221	CcSEcCtD
Loxapine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000228	0.00218	CcSEcCtD
Loxapine—HRH1—telencephalon—Alzheimer's disease	0.000228	0.00285	CbGeAlD
Loxapine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000227	0.00216	CcSEcCtD
Loxapine—HTR1D—nervous system—Alzheimer's disease	0.000227	0.00283	CbGeAlD
Loxapine—HTR1B—central nervous system—Alzheimer's disease	0.000225	0.00281	CbGeAlD
Loxapine—Thiothixene—HTR6—Alzheimer's disease	0.000225	0.0558	CrCbGaD
Loxapine—HTR2C—nervous system—Alzheimer's disease	0.000224	0.0028	CbGeAlD
Loxapine—ADRA2A—telencephalon—Alzheimer's disease	0.000224	0.0028	CbGeAlD
Loxapine—CHRM2—central nervous system—Alzheimer's disease	0.000224	0.0028	CbGeAlD
Loxapine—SLC6A3—central nervous system—Alzheimer's disease	0.000224	0.00279	CbGeAlD
Loxapine—Asthenia—Donepezil—Alzheimer's disease	0.000222	0.00212	CcSEcCtD
Loxapine—DRD1—brain—Alzheimer's disease	0.000221	0.00275	CbGeAlD
Loxapine—ADRB1—nervous system—Alzheimer's disease	0.00022	0.00275	CbGeAlD
Loxapine—Pruritus—Donepezil—Alzheimer's disease	0.000219	0.00209	CcSEcCtD
Loxapine—SLC6A3—cerebellum—Alzheimer's disease	0.000218	0.00273	CbGeAlD
Loxapine—HTR1D—central nervous system—Alzheimer's disease	0.000218	0.00272	CbGeAlD
Loxapine—HTR2C—central nervous system—Alzheimer's disease	0.000216	0.0027	CbGeAlD
Loxapine—HTR3A—brain—Alzheimer's disease	0.000213	0.00266	CbGeAlD
Loxapine—SLC6A4—nervous system—Alzheimer's disease	0.000213	0.00265	CbGeAlD
Loxapine—ADRB1—central nervous system—Alzheimer's disease	0.000212	0.00265	CbGeAlD
Loxapine—CHRM1—nervous system—Alzheimer's disease	0.000212	0.00264	CbGeAlD
Loxapine—HTR2A—forebrain—Alzheimer's disease	0.000207	0.00259	CbGeAlD
Loxapine—Hypersensitivity—Memantine—Alzheimer's disease	0.000207	0.00198	CcSEcCtD
Loxapine—Dizziness—Donepezil—Alzheimer's disease	0.000205	0.00195	CcSEcCtD
Loxapine—SLC6A4—central nervous system—Alzheimer's disease	0.000205	0.00256	CbGeAlD
Loxapine—CHRM1—central nervous system—Alzheimer's disease	0.000204	0.00255	CbGeAlD
Loxapine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000203	0.00193	CcSEcCtD
Loxapine—Asthenia—Memantine—Alzheimer's disease	0.000202	0.00192	CcSEcCtD
Loxapine—Pruritus—Memantine—Alzheimer's disease	0.000199	0.0019	CcSEcCtD
Loxapine—Amoxapine—HTR6—Alzheimer's disease	0.000198	0.049	CrCbGaD
Loxapine—Asthenia—Rivastigmine—Alzheimer's disease	0.000197	0.00188	CcSEcCtD
Loxapine—Vomiting—Donepezil—Alzheimer's disease	0.000197	0.00188	CcSEcCtD
Loxapine—Rash—Donepezil—Alzheimer's disease	0.000195	0.00186	CcSEcCtD
Loxapine—Dermatitis—Donepezil—Alzheimer's disease	0.000195	0.00186	CcSEcCtD
Loxapine—Pruritus—Rivastigmine—Alzheimer's disease	0.000195	0.00186	CcSEcCtD
Loxapine—Headache—Donepezil—Alzheimer's disease	0.000194	0.00185	CcSEcCtD
Loxapine—HTR2A—telencephalon—Alzheimer's disease	0.000191	0.00238	CbGeAlD
Loxapine—CHRM3—nervous system—Alzheimer's disease	0.00019	0.00237	CbGeAlD
Loxapine—HTR1A—nervous system—Alzheimer's disease	0.000189	0.00236	CbGeAlD
Loxapine—SLC6A2—nervous system—Alzheimer's disease	0.000187	0.00234	CbGeAlD
Loxapine—Dizziness—Memantine—Alzheimer's disease	0.000186	0.00177	CcSEcCtD
Loxapine—Nausea—Donepezil—Alzheimer's disease	0.000184	0.00175	CcSEcCtD
Loxapine—CHRM3—central nervous system—Alzheimer's disease	0.000183	0.00228	CbGeAlD
Loxapine—Dizziness—Rivastigmine—Alzheimer's disease	0.000182	0.00173	CcSEcCtD
Loxapine—HTR1A—central nervous system—Alzheimer's disease	0.000182	0.00227	CbGeAlD
Loxapine—HTR7—nervous system—Alzheimer's disease	0.000181	0.00225	CbGeAlD
Loxapine—SLC6A2—central nervous system—Alzheimer's disease	0.00018	0.00225	CbGeAlD
Loxapine—HTR1B—brain—Alzheimer's disease	0.000179	0.00223	CbGeAlD
Loxapine—Vomiting—Memantine—Alzheimer's disease	0.000179	0.00171	CcSEcCtD
Loxapine—CHRM2—brain—Alzheimer's disease	0.000178	0.00222	CbGeAlD
Loxapine—HTR1A—cerebellum—Alzheimer's disease	0.000178	0.00222	CbGeAlD
Loxapine—SLC6A3—brain—Alzheimer's disease	0.000177	0.00221	CbGeAlD
Loxapine—Rash—Memantine—Alzheimer's disease	0.000177	0.00169	CcSEcCtD
Loxapine—Dermatitis—Memantine—Alzheimer's disease	0.000177	0.00169	CcSEcCtD
Loxapine—Headache—Memantine—Alzheimer's disease	0.000176	0.00168	CcSEcCtD
Loxapine—Vomiting—Rivastigmine—Alzheimer's disease	0.000175	0.00167	CcSEcCtD
Loxapine—ADRA1A—nervous system—Alzheimer's disease	0.000174	0.00217	CbGeAlD
Loxapine—HTR7—central nervous system—Alzheimer's disease	0.000174	0.00217	CbGeAlD
Loxapine—Rash—Rivastigmine—Alzheimer's disease	0.000174	0.00165	CcSEcCtD
Loxapine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000173	0.00165	CcSEcCtD
Loxapine—HTR1D—brain—Alzheimer's disease	0.000173	0.00216	CbGeAlD
Loxapine—Headache—Rivastigmine—Alzheimer's disease	0.000172	0.00164	CcSEcCtD
Loxapine—Trifluoperazine—CALM1—Alzheimer's disease	0.000172	0.0427	CrCbGaD
Loxapine—HTR2C—brain—Alzheimer's disease	0.000172	0.00214	CbGeAlD
Loxapine—Asenapine—SLC6A4—Alzheimer's disease	0.000171	0.0424	CrCbGaD
Loxapine—DRD2—nervous system—Alzheimer's disease	0.000171	0.00213	CbGeAlD
Loxapine—HTR7—cerebellum—Alzheimer's disease	0.00017	0.00212	CbGeAlD
Loxapine—ADRB1—brain—Alzheimer's disease	0.000168	0.0021	CbGeAlD
Loxapine—ADRA1A—central nervous system—Alzheimer's disease	0.000168	0.00209	CbGeAlD
Loxapine—Nausea—Memantine—Alzheimer's disease	0.000167	0.00159	CcSEcCtD
Loxapine—ADRA2C—nervous system—Alzheimer's disease	0.000166	0.00207	CbGeAlD
Loxapine—DRD2—central nervous system—Alzheimer's disease	0.000164	0.00205	CbGeAlD
Loxapine—ADRA1A—cerebellum—Alzheimer's disease	0.000164	0.00204	CbGeAlD
Loxapine—Nausea—Rivastigmine—Alzheimer's disease	0.000163	0.00156	CcSEcCtD
Loxapine—SLC6A4—brain—Alzheimer's disease	0.000163	0.00203	CbGeAlD
Loxapine—CHRM1—brain—Alzheimer's disease	0.000162	0.00202	CbGeAlD
Loxapine—DRD2—cerebellum—Alzheimer's disease	0.000161	0.002	CbGeAlD
Loxapine—ADRA2C—central nervous system—Alzheimer's disease	0.00016	0.00199	CbGeAlD
Loxapine—ADRA2C—cerebellum—Alzheimer's disease	0.000156	0.00195	CbGeAlD
Loxapine—Trifluoperazine—HTR6—Alzheimer's disease	0.000155	0.0385	CrCbGaD
Loxapine—Quetiapine—HTR6—Alzheimer's disease	0.000151	0.0374	CrCbGaD
Loxapine—CHRM3—brain—Alzheimer's disease	0.000145	0.00181	CbGeAlD
Loxapine—HTR1A—brain—Alzheimer's disease	0.000144	0.0018	CbGeAlD
Loxapine—SLC6A2—brain—Alzheimer's disease	0.000143	0.00179	CbGeAlD
Loxapine—HTR7—brain—Alzheimer's disease	0.000138	0.00172	CbGeAlD
Loxapine—HRH1—nervous system—Alzheimer's disease	0.000135	0.00168	CbGeAlD
Loxapine—ADRA1A—brain—Alzheimer's disease	0.000133	0.00166	CbGeAlD
Loxapine—ADRA2A—nervous system—Alzheimer's disease	0.000132	0.00165	CbGeAlD
Loxapine—Asenapine—HTR2A—Alzheimer's disease	0.000131	0.0326	CrCbGaD
Loxapine—DRD2—brain—Alzheimer's disease	0.00013	0.00163	CbGeAlD
Loxapine—HRH1—central nervous system—Alzheimer's disease	0.00013	0.00162	CbGeAlD
Loxapine—Clozapine—HTR6—Alzheimer's disease	0.00013	0.0321	CrCbGaD
Loxapine—ADRA2A—central nervous system—Alzheimer's disease	0.000127	0.00159	CbGeAlD
Loxapine—ADRA2C—brain—Alzheimer's disease	0.000127	0.00158	CbGeAlD
Loxapine—ADRA2A—cerebellum—Alzheimer's disease	0.000125	0.00155	CbGeAlD
Loxapine—Asenapine—CYP2D6—Alzheimer's disease	0.00012	0.0298	CrCbGaD
Loxapine—HTR2A—nervous system—Alzheimer's disease	0.000113	0.0014	CbGeAlD
Loxapine—HTR2A—central nervous system—Alzheimer's disease	0.000108	0.00135	CbGeAlD
Loxapine—HTR2A—cerebellum—Alzheimer's disease	0.000106	0.00132	CbGeAlD
Loxapine—HRH1—brain—Alzheimer's disease	0.000103	0.00129	CbGeAlD
Loxapine—ADRA2A—brain—Alzheimer's disease	0.000101	0.00126	CbGeAlD
Loxapine—Trazodone—SLC6A4—Alzheimer's disease	9.18e-05	0.0228	CrCbGaD
Loxapine—HTR2A—brain—Alzheimer's disease	8.6e-05	0.00107	CbGeAlD
Loxapine—Azelastine—CYP2D6—Alzheimer's disease	7.78e-05	0.0193	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—Alzheimer's disease	7.67e-05	0.019	CrCbGaD
Loxapine—Amoxapine—SLC6A4—Alzheimer's disease	7.56e-05	0.0188	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—Alzheimer's disease	7.54e-05	0.0187	CrCbGaD
Loxapine—Olanzapine—HTR2A—Alzheimer's disease	7.3e-05	0.0181	CrCbGaD
Loxapine—Chlordiazepoxide—CYP2D6—Alzheimer's disease	7.14e-05	0.0177	CrCbGaD
Loxapine—Trazodone—HTR2A—Alzheimer's disease	7.06e-05	0.0175	CrCbGaD
Loxapine—Zuclopenthixol—CYP2D6—Alzheimer's disease	7.02e-05	0.0174	CrCbGaD
Loxapine—Olanzapine—CYP2D6—Alzheimer's disease	6.68e-05	0.0166	CrCbGaD
Loxapine—Thiothixene—HTR2A—Alzheimer's disease	6.61e-05	0.0164	CrCbGaD
Loxapine—Trazodone—CYP2D6—Alzheimer's disease	6.45e-05	0.016	CrCbGaD
Loxapine—Thiothixene—CYP2D6—Alzheimer's disease	6.05e-05	0.015	CrCbGaD
Loxapine—Amoxapine—HTR2A—Alzheimer's disease	5.81e-05	0.0144	CrCbGaD
Loxapine—Prochlorperazine—CYP2D6—Alzheimer's disease	5.78e-05	0.0143	CrCbGaD
Loxapine—Amoxapine—CYP2D6—Alzheimer's disease	5.32e-05	0.0132	CrCbGaD
Loxapine—Diazepam—PTGS1—Alzheimer's disease	5.19e-05	0.0129	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—Alzheimer's disease	4.57e-05	0.0113	CrCbGaD
Loxapine—Quetiapine—HTR2A—Alzheimer's disease	4.43e-05	0.011	CrCbGaD
Loxapine—Quetiapine—CYP2D6—Alzheimer's disease	4.05e-05	0.0101	CrCbGaD
Loxapine—Clozapine—HTR2A—Alzheimer's disease	3.81e-05	0.00946	CrCbGaD
Loxapine—Clozapine—CYP2D6—Alzheimer's disease	3.49e-05	0.00865	CrCbGaD
Loxapine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.02e-06	2.05e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.02e-06	2.05e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.02e-06	2.05e-05	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.02e-06	2.04e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.02e-06	2.04e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.02e-06	2.04e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.02e-06	2.04e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.02e-06	2.04e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.01e-06	2.04e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.01e-06	2.03e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.01e-06	2.03e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2e-06	2.02e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2e-06	2.02e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2e-06	2.02e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2e-06	2.02e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.99e-06	2.02e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	1.99e-06	2.01e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	2.01e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.98e-06	2e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.98e-06	2e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	1.97e-06	2e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—Alzheimer's disease	1.97e-06	1.99e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.96e-06	1.98e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—Alzheimer's disease	1.96e-06	1.98e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.96e-06	1.98e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	1.96e-06	1.98e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.96e-06	1.98e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.95e-06	1.98e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-06	1.97e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.95e-06	1.97e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.95e-06	1.97e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	1.96e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	1.94e-06	1.96e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.93e-06	1.95e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.93e-06	1.95e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.92e-06	1.94e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.92e-06	1.94e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.91e-06	1.93e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.89e-06	1.91e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	1.87e-06	1.89e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.87e-06	1.89e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.86e-06	1.89e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.86e-06	1.88e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.85e-06	1.87e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.84e-06	1.86e-05	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.84e-06	1.86e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.84e-06	1.86e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.84e-06	1.86e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.83e-06	1.85e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.83e-06	1.85e-05	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.82e-06	1.84e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.82e-06	1.84e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	1.84e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.81e-06	1.83e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.81e-06	1.83e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.81e-06	1.83e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.81e-06	1.83e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.8e-06	1.82e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—Alzheimer's disease	1.8e-06	1.82e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.8e-06	1.82e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.79e-06	1.81e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	1.8e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.78e-06	1.8e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.78e-06	1.79e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.77e-06	1.79e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.77e-06	1.79e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.77e-06	1.79e-05	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	1.78e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.76e-06	1.78e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.76e-06	1.77e-05	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	1.77e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	1.76e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-06	1.76e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-06	1.76e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	1.75e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.73e-06	1.75e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.73e-06	1.75e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	1.74e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.72e-06	1.74e-05	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	1.72e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.7e-06	1.72e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.69e-06	1.71e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.68e-06	1.7e-05	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.68e-06	1.7e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.68e-06	1.69e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	1.69e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	1.66e-06	1.68e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.66e-06	1.68e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-06	1.68e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-06	1.68e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.66e-06	1.67e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.65e-06	1.67e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.65e-06	1.67e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.62e-06	1.63e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	1.62e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	1.62e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	1.61e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	1.61e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.58e-06	1.6e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-06	1.58e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	1.57e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	1.56e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.55e-06	1.56e-05	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.55e-06	1.56e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.53e-06	1.55e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.53e-06	1.55e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.53e-06	1.54e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.52e-06	1.54e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.52e-06	1.54e-05	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.52e-06	1.54e-05	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.52e-06	1.53e-05	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.51e-06	1.53e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	1.53e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	1.53e-05	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.51e-06	1.52e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.51e-06	1.52e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.5e-06	1.52e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	1.52e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.5e-06	1.52e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.5e-06	1.51e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.49e-06	1.51e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.49e-06	1.51e-05	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.49e-06	1.51e-05	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.49e-06	1.51e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.49e-06	1.51e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.48e-06	1.5e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	1.5e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-06	1.5e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-06	1.49e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	1.49e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-06	1.49e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	1.48e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-06	1.48e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.45e-06	1.46e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.45e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.43e-06	1.44e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.44e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.41e-06	1.43e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.41e-06	1.42e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-06	1.42e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.4e-06	1.42e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.39e-06	1.4e-05	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.4e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	1.4e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.38e-06	1.4e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	1.4e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.38e-06	1.4e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.38e-06	1.39e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.38e-06	1.39e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.37e-06	1.39e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.37e-06	1.39e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	1.39e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.37e-06	1.39e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.37e-06	1.38e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	1.38e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.38e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-06	1.37e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	1.37e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	1.37e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-06	1.37e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.35e-06	1.37e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	1.37e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	1.36e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.32e-06	1.34e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.33e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.3e-06	1.32e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.3e-06	1.32e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.3e-06	1.31e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.29e-06	1.31e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.28e-06	1.3e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.28e-06	1.29e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.28e-06	1.29e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.28e-06	1.29e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	1.29e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.27e-06	1.29e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.27e-06	1.28e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	1.28e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.26e-06	1.27e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.26e-06	1.27e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	1.27e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.25e-06	1.27e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	1.26e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.25e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.22e-06	1.23e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.2e-06	1.22e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.19e-06	1.21e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.19e-06	1.2e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.17e-06	1.19e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.17e-06	1.19e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.17e-06	1.18e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.18e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.17e-06	1.18e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.18e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.18e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	1.17e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.17e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-06	1.17e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-06	1.16e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.13e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.13e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.1e-06	1.11e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.09e-06	1.11e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-06	1.1e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.09e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.08e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.07e-06	1.08e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	1.08e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.06e-06	1.07e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.04e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.03e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	9.91e-07	1e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	9.88e-07	9.98e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.82e-07	9.93e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	9.79e-07	9.89e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	9.75e-07	9.86e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—Alzheimer's disease	9.68e-07	9.78e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.66e-07	9.77e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.64e-07	9.75e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	9.61e-07	9.72e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	9.58e-07	9.69e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	9.49e-07	9.59e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.46e-07	9.57e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.45e-07	9.55e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.4e-07	9.5e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	9.14e-07	9.24e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	9e-07	9.09e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.99e-07	9.09e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	8.88e-07	8.98e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.85e-07	8.94e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.83e-07	8.92e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	8.8e-07	8.89e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	8.79e-07	8.89e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	8.77e-07	8.87e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	8.69e-07	8.78e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.66e-07	8.76e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.29e-07	8.38e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	8.16e-07	8.25e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	8.14e-07	8.23e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	8.12e-07	8.21e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	8.09e-07	8.18e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	8.05e-07	8.14e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	8.01e-07	8.1e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.99e-07	8.08e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	7.42e-07	7.51e-06	CbGpPWpGaD
